Sutro Biopharma 宣布新一代 ITGB6 靶向 ADC 药物 STRO-006 一期临床试验完成首例患者给药,用于治疗晚期实体瘤
Sutro Biopharma 宣布新一代 ITGB6 靶向 ADC 药物 STRO-006 一期临床试验完成首例患者给药,用于治疗晚期实体瘤
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.